Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 40001 - 40025 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Eugenol	Approved Investigational	STAT1	6772	downregulated	Eugenol results in decreased expression of STAT1 mRNA	2q32.2	A22388
Eugenol	Approved Investigational	STAT4	6775	upregulated	Eugenol results in increased expression of STAT4 mRNA	2q32.2-q32.3	A22388
Eugenol	Approved Investigational	STAT5B	6777	upregulated	Eugenol results in increased expression of STAT5B mRNA	17q21.2	A22388
Eugenol	Approved Investigational	TLR4	7099	upregulated	Eugenol results in increased expression of TLR4 mRNA	9q33.1	A22599
Eugenol	Approved Investigational	TNFAIP3	7128	upregulated	Eugenol results in increased expression of TNFAIP3 mRNA	6q23.3	A21532
Eugenol	Approved Investigational	TNFAIP6	7130	upregulated	Eugenol results in increased expression of TNFAIP6 mRNA	2q23.3	A22388 A21532
Eugenol	Approved Investigational	TP63	8626	downregulated	Eugenol results in decreased expression of TP63 mRNA	3q28	A22599
Eugenol	Approved Investigational	TXN2	25828	upregulated	Eugenol results in increased expression of TXN2 mRNA	22q12.3	A21074
Eugenol	Approved Investigational	TXNRD1	7296	upregulated	Eugenol results in increased expression of TXNRD1 mRNA	12q23.3	A21074
Eugenol	Approved Investigational	TXNRD2	10587	upregulated	Eugenol results in increased expression of TXNRD2 mRNA	22q11.21	A21074
Eugenol	Approved Investigational	UGDH	7358	upregulated	Eugenol results in increased expression of UGDH mRNA	4p14	A22606
Eugenol	Approved Investigational	UGT1A6	54578	upregulated	Eugenol results in increased expression of UGT1A6 mRNA	2q37.1	A21074
Eugenol	Approved Investigational	VDR	7421	upregulated	Eugenol results in increased expression of VDR mRNA	12q13.11	A22388
Eugenol	Approved Investigational	ZBTB17	7709	downregulated	Eugenol results in decreased expression of ZBTB17 mRNA	1p36.13	A22388
Exemestane	Approved Investigational	ABCG4	64137	upregulated	exemestane results in increased expression of ABCG4 mRNA	11q23.3	A20550
Exemestane	Approved Investigational	ADCYAP1R1	117	upregulated	exemestane results in increased expression of ADCYAP1R1 mRNA	7p14.3	A20550
Exemestane	Approved Investigational	AREG	374	upregulated	exemestane results in increased expression of AREG mRNA	4q13.3	A21347
Exemestane	Approved Investigational	CD83	9308	upregulated	exemestane results in increased expression of CD83 mRNA	6p23	A20550
Exemestane	Approved Investigational	DAB2	1601	upregulated	exemestane results in increased expression of DAB2 mRNA	5p13.1	A20550
Exemestane	Approved Investigational	EBF1	1879	upregulated	exemestane results in increased expression of EBF1 mRNA	5q33.3	A20550
Exemestane	Approved Investigational	GPC2	221914	upregulated	exemestane results in increased expression of GPC2 mRNA	7q22.1	A20550
Exemestane	Approved Investigational	HOXD11	3237	upregulated	exemestane results in increased expression of HOXD11 mRNA	2q31.1	A20550
Exemestane	Approved Investigational	INPP5K	51763	upregulated	exemestane results in increased expression of INPP5K mRNA	17p13.3	A20550
Exemestane	Approved Investigational	INTS4	92105	upregulated	exemestane results in increased expression of INTS4 mRNA	11q14.1	A20550
Exemestane	Approved Investigational	KIF13B	23303	upregulated	exemestane results in increased expression of KIF13B mRNA	8p12	A20550

Displaying entries 40001 - 40025 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability